Publication
ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma.
Himalee S Sabnis, Melinda Pauly, Eric S Schafer, Robin E Norris, Kevin Ginn, Tsz Yeung, Naresh Kumar, Stacy Senn, Haley Cowan, Deborah DeRyckere, Christopher J Forlenza, Neerav Shukla
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: Relapsed and refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/T-LL) remains a therapeutic challenge. Allogeneic hematopoietic stem cell transplantation (HSCT) after achieving complete remission (CR) offers the only chance of cure, but effective modalities to achieve…
Read on PubMedLinked entities
Linked entities (2)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 1
- trialNCT03328104registry_reference1.00
Candidate 1
- cancerLeukemiadictionary0.60
Registered trialsNCT03328104
Curated evidence
Evidence citing this paper (0)
Data not yet available